Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Tai Chi Training on Metabolic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03107741
Recruitment Status : Completed
First Posted : April 11, 2017
Last Update Posted : July 29, 2019
Sponsor:
Information provided by (Responsible Party):
Angus Yu, The Hong Kong Polytechnic University

Brief Summary:
Metabolic syndrome (MetS) is a serious public health problem in Hong Kong and worldwide. Older adults, the age group with the highest prevalence of MetS, may prefer specific exercise modalities that are suitable for their regular participation to manage MetS. This project aims to evaluate the effectiveness of Tai Chi, a very suitable exercise for older adults, to alleviate MetS in older population

Condition or disease Intervention/treatment Phase
Metabolic Syndrome Other: Generic Fitness Other: Tai Chi Not Applicable

Detailed Description:

PURPOSE/OBJECTIVE: Metabolic syndrome (MetS) is a serious public health problem in Hong Kong and worldwide. Older adults, the age group with the highest prevalence of MetS, may prefer specific exercise modalities that are suitable for their regular participation to manage MetS. This project aims to evaluate the effectiveness of Tai Chi, a very suitable exercise for older adults, to alleviate MetS in older population.

DESIGN & METHODS: This study will adopt a three-arm randomized controlled trial with pretest-posttest design. Older adults aged 50 years or above with abdominal obesity will be randomly assigned to passive control, active control, and Tai Chi groups. Subjects assigned to Tai Chi and active control groups will be provided with a 12-weeks program of Tai Chi and generic fitness, respectively. No intervention will be given to the passive control group. Outcome measures including MetS components (waist circumference, blood pressure, blood glucose, triglyceride and high density lipoprotein-cholesterol) will be assessed at baseline, post-intervention, and follow-up (6 months after the end of intervention) assessments in all groups.

HYPOTHESES: We hypothesize that: 1) improvements of waist circumference and other indicators of MetS are found in Tai Chi group but not in passive control group and 2) improvements of waist circumference and other indicators of MetS are greater in Tai Chi group than active control group.

MAIN OUTCOME MEASURES: Waist circumference, systolic and diastolic blood pressure, blood glucose, triglyceride and high density lipoprotein-cholesterol

DATA ANALYSIS: Two-way (time x intervention) mixed mode ANOVA with post hoc test.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 543 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: Effectiveness of Tai Chi Training to Alleviate Metabolic Syndrome in Abdominal Obese Older Adults: A Randomized Controlled Trial
Actual Study Start Date : October 2015
Actual Primary Completion Date : February 2019
Actual Study Completion Date : February 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
No Intervention: Passive Control
Subjects in this group do not received any intervention.
Placebo Comparator: Generic Fitness
Subjects in this groups will receive three fitness lessons in a week while each session last for 1 hour throughout the 12 weeks experimental period
Other: Generic Fitness
Subjects in this groups will receive three fitness lessons in a week while each session last for 1 hour throughout the 12 weeks experimental period

Active Comparator: Tai Chi
Subjects in this groups will receive three tai chi lessons in a week while each session last for 1 hour throughout the 12 weeks experimental period
Other: Tai Chi
Subjects in this groups will receive three Tai Chi lessons in a week while each session last for 1 hour throughout the 12 weeks experimental period




Primary Outcome Measures :
  1. Waist circumference (Baseline Assessment) [ Time Frame: 0 month ]
    Waist circumference will be measured midway between the lowest rib and the superior border of the iliac crest using an inelastic measuring tape on the bare skin to the nearest 0.1 cm. Measurement will be performed at the end of normal expiration.

  2. Waist circumference (Post-Intervention Assessment) [ Time Frame: 3 months ]
    Waist circumference will be measured midway between the lowest rib and the superior border of the iliac crest using an inelastic measuring tape on the bare skin to the nearest 0.1 cm. Measurement will be performed at the end of normal expiration.

  3. Waist circumference (Follow-up Assessment) [ Time Frame: 9 months ]
    Waist circumference will be measured midway between the lowest rib and the superior border of the iliac crest using an inelastic measuring tape on the bare skin to the nearest 0.1 cm. Measurement will be performed at the end of normal expiration.


Secondary Outcome Measures :
  1. Systolic and diastolic blood pressure (Baseline Assessment) [ Time Frame: 0 month ]
    Blood pressure measurement will be measured on the right arm after 5-minute seated rest using the Datascope Accutorr Plus BP Monitor. Systolic and diastolic blood pressure will be obtained over brachial artery region with the arm supported at heart level using appropriate sized cuff. Average of two measurements taken with 1-minute interval will be recorded for analysis.

  2. Systolic and diastolic blood pressure (Post-Intervention Assessment) [ Time Frame: 3 months ]
    Blood pressure measurement will be measured on the right arm after 5-minute seated rest using the Datascope Accutorr Plus BP Monitor. Systolic and diastolic blood pressure will be obtained over brachial artery region with the arm supported at heart level using appropriate sized cuff. Average of two measurements taken with 1-minute interval will be recorded for analysis.

  3. Systolic and diastolic blood pressure (Follow-up Assessment) [ Time Frame: 9 months ]
    Blood pressure measurement will be measured on the right arm after 5-minute seated rest using the Datascope Accutorr Plus BP Monitor. Systolic and diastolic blood pressure will be obtained over brachial artery region with the arm supported at heart level using appropriate sized cuff. Average of two measurements taken with 1-minute interval will be recorded for analysis.

  4. Fasting blood glucose (Baseline Assessment) [ Time Frame: 0 month ]
    Biochemical measurements will be performed in venous blood sample collected after overnight fast. Subjects will come to laboratory after an overnight ≥ 8 hours fasting. Subjects will sit in a quiet environment for 15-minute prior to blood collection. Venous blood will be drawn from an antecubital vein in the forearm by a licensed phlebotomist. After collection of venous blood, blood samples will be dispensed into a lithium heparin plastic tube to prevent coagulation. The obtain blood samples will be used to measure glucose, triglyceride and HDL-cholesterol levels by an accredited medical laboratory.

  5. Fasting blood glucose (Post-Intervention Assessment) [ Time Frame: 3 month ]
    Biochemical measurements will be performed in venous blood sample collected after overnight fast. Subjects will come to laboratory after an overnight ≥ 8 hours fasting. Subjects will sit in a quiet environment for 15-minute prior to blood collection. Venous blood will be drawn from an antecubital vein in the forearm by a licensed phlebotomist. After collection of venous blood, blood samples will be dispensed into a lithium heparin plastic tube to prevent coagulation. The obtain blood samples will be used to measure glucose, triglyceride and HDL-cholesterol levels by an accredited medical laboratory.

  6. Fasting blood glucose (Follow-up Assessment) [ Time Frame: 9 months ]
    Biochemical measurements will be performed in venous blood sample collected after overnight fast. Subjects will come to laboratory after an overnight ≥ 8 hours fasting. Subjects will sit in a quiet environment for 15-minute prior to blood collection. Venous blood will be drawn from an antecubital vein in the forearm by a licensed phlebotomist. After collection of venous blood, blood samples will be dispensed into a lithium heparin plastic tube to prevent coagulation. The obtain blood samples will be used to measure glucose, triglyceride and HDL-cholesterol levels by an accredited medical laboratory.

  7. Blood triglyceride(Baseline Assessment) [ Time Frame: 0 month ]
    Biochemical measurements will be performed in venous blood sample collected after overnight fast. Subjects will come to laboratory after an overnight ≥ 8 hours fasting. Subjects will sit in a quiet environment for 15-minute prior to blood collection. Venous blood will be drawn from an antecubital vein in the forearm by a licensed phlebotomist. After collection of venous blood, blood samples will be dispensed into a lithium heparin plastic tube to prevent coagulation. The obtain blood samples will be used to measure glucose, triglyceride and HDL-cholesterol levels by an accredited medical laboratory.

  8. Blood triglyceride (Post-Intervention Assessment) [ Time Frame: 3 months ]
    Biochemical measurements will be performed in venous blood sample collected after overnight fast. Subjects will come to laboratory after an overnight ≥ 8 hours fasting. Subjects will sit in a quiet environment for 15-minute prior to blood collection. Venous blood will be drawn from an antecubital vein in the forearm by a licensed phlebotomist. After collection of venous blood, blood samples will be dispensed into a lithium heparin plastic tube to prevent coagulation. The obtain blood samples will be used to measure glucose, triglyceride and HDL-cholesterol levels by an accredited medical laboratory.

  9. Blood triglyceride (Follow-up Assessment) [ Time Frame: 9 months ]
    Biochemical measurements will be performed in venous blood sample collected after overnight fast. Subjects will come to laboratory after an overnight ≥ 8 hours fasting. Subjects will sit in a quiet environment for 15-minute prior to blood collection. Venous blood will be drawn from an antecubital vein in the forearm by a licensed phlebotomist. After collection of venous blood, blood samples will be dispensed into a lithium heparin plastic tube to prevent coagulation. The obtain blood samples will be used to measure glucose, triglyceride and HDL-cholesterol levels by an accredited medical laboratory.

  10. High density lipoprotein-cholesterol (Baseline Assessment) [ Time Frame: 0 month ]
    Biochemical measurements will be performed in venous blood sample collected after overnight fast. Subjects will come to laboratory after an overnight ≥ 8 hours fasting. Subjects will sit in a quiet environment for 15-minute prior to blood collection. Venous blood will be drawn from an antecubital vein in the forearm by a licensed phlebotomist. After collection of venous blood, blood samples will be dispensed into a lithium heparin plastic tube to prevent coagulation. The obtain blood samples will be used to measure glucose, triglyceride and HDL-cholesterol levels by an accredited medical laboratory.

  11. High density lipoprotein-cholesterol (Post-Intervention Assessment) [ Time Frame: 3 months ]
    Biochemical measurements will be performed in venous blood sample collected after overnight fast. Subjects will come to laboratory after an overnight ≥ 8 hours fasting. Subjects will sit in a quiet environment for 15-minute prior to blood collection. Venous blood will be drawn from an antecubital vein in the forearm by a licensed phlebotomist. After collection of venous blood, blood samples will be dispensed into a lithium heparin plastic tube to prevent coagulation. The obtain blood samples will be used to measure glucose, triglyceride and HDL-cholesterol levels by an accredited medical laboratory.

  12. High density lipoprotein-cholesterol (Follow-up Assessment) [ Time Frame: 9 months ]
    Biochemical measurements will be performed in venous blood sample collected after overnight fast. Subjects will come to laboratory after an overnight ≥ 8 hours fasting. Subjects will sit in a quiet environment for 15-minute prior to blood collection. Venous blood will be drawn from an antecubital vein in the forearm by a licensed phlebotomist. After collection of venous blood, blood samples will be dispensed into a lithium heparin plastic tube to prevent coagulation. The obtain blood samples will be used to measure glucose, triglyceride and HDL-cholesterol levels by an accredited medical laboratory.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Ethnic Chinese
  • Abdominal Obese: Fulfill the criteria of International Diabetes Federation (IDF) and National Cholesterol Education Program (NCEP) for abdominal obesity using Asian-specific cut off (waist circumference ≥ 90 cm for male; ≥ 80 cm for female)

Exclusion Criteria:

  • Serious medical and somatic condition that prevent participation from generic fitness/Tai Chi exercise
  • Serious chronic diseases that known to affect mobility (eg. Neurological disease, musculoskeletal disorder and autoimmune diseases)
  • Under treatment of serious chronic diseases (eg. Cancer treatment)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03107741


Locations
Layout table for location information
China
The Hong Kong Polytechnic University
Hong Kong, China, 852
Sponsors and Collaborators
Angus Yu
Layout table for additonal information
Responsible Party: Angus Yu, Research Assistant, The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier: NCT03107741    
Other Study ID Numbers: Tai Chi and Metabolic Syndrome
First Posted: April 11, 2017    Key Record Dates
Last Update Posted: July 29, 2019
Last Verified: July 2019
Keywords provided by Angus Yu, The Hong Kong Polytechnic University:
Metabolic Syndrome
Waist circumference
Blood pressure
Triglyceride
HDL cholesterol
Additional relevant MeSH terms:
Layout table for MeSH terms
Metabolic Syndrome
Syndrome
Disease
Pathologic Processes
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases